Abstracts tagged "Communication"

Abstract Number: 1861 • 2019 ACR/ARP Annual Meeting
Use of a Novel Electronic Auto-notification Process to Manage Transitions of Care in Rheumatic Patients on DMARD Therapy
Megan Bielawski¹, Eric Newman ² and Lisa Schroeder ¹, ¹Geisinger Medical Center, Danville, PA, ²Geisinger, Danville, PA
Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatologic diseases. In our prior study of rheumatoid arthritis patients and hospital admissions,…
Abstract Number: 2271 • 2019 ACR/ARP Annual Meeting
Sexual Health, Intimacy and Rheumatology Practices
Julie Schwartzman-Morris¹, Arianna Leo ² and Preeya Nandkumar ², ¹Division of Rheumatology, Northwell Health, Great Neck, NY, ²Division of Rheumatology, Northwell Health, Great Neck
Background/Purpose: Patients with chronic illness often face challenges with their sexual health and intimacy. The issues can be inherent to the disease state, self-image, or…
Abstract Number: 1925 • 2018 ACR/ARHP Annual Meeting
Goal Concordance in Rheumatoid Arthritis: Beyond Pain Reduction, Is There Agreement?
Jennifer Barton^1,2, Shelia Markwardt², Allison Schue¹, Somnath Saha^2,3 and Edward H. Yelin⁴, ¹VA Portland Health Care System, Portland, OR, ²Oregon Health & Science University, Portland, OR, ³Medicine, VA Portland Health Care System, Portland, OR, ⁴Medicine/Rheumatology, University of California San Francisco, San Francisco, CA
Background/Purpose: Goal concordance between patients with chronic diseases and their clinicians has been linked to improved outcomes, but not explored in rheumatoid arthritis (RA). Our…
Abstract Number: 1928 • 2018 ACR/ARHP Annual Meeting
Patient-Physician Communication about Medication Costs in Rheumatoid Arthritis
K. Julia Kaal¹, Nick Bansback^1,2,3, Aslam Anis^4,5 and Mark Harrison^5,6,7,8, ¹University of British Columbia, Vancouver, BC, Canada, ²St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, ³Arthritis Research Canada, Richmond, BC, Canada, ⁴University of British Columbia, School of Population and Public Health, Vancouver, BC, Canada, ⁵Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, ⁶Arthritis Research Canada, Vancouver, BC, Canada, ⁷Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, ⁸Collaborations in Outcomes Research and Evaluation, Vancouver, BC, Canada
Background/Purpose: Patients often have to pay for prescription medications out-of-pocket and cost-related nonadherence is a recognized problem. The treatment of rheumatoid arthritis is associated with…
Abstract Number: 2187 • 2018 ACR/ARHP Annual Meeting
Specialist Link Telephone Advice Cost Effectively Enhances Rheumatology Patient Care in Alberta, Canada
Yolanda Martens-Vanhilst¹, Dianne P. Mosher², Linda Slocombe¹ and Paul MacMullan³, ¹University of Calgary, Calgary, AB, Canada, ²Med, University of Calgary, Calgary, AB, Canada, ³Medicine, Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: The Calgary zone of Alberta Health Services serves a population of almost 2million Canadians over a wide geographical area and is underserved in terms…
Abstract Number: 2341 • 2018 ACR/ARHP Annual Meeting
A Link between Quality of Patient–Rheumatologist Communication and Patient Healthcare Needs in Psoriatic Arthritis: An Online Survey of US-Based Patients and Rheumatologists
Ana-Maria Orbai¹, Laura C. Coates², Valderilio F Azevedo³, Amit Garg⁴, Amar Majjhoo⁵, Christopher E M Griffiths⁶, Pamela Young⁷, Joseph C Cappelleri⁸, Jade Moser⁹ and Lara Fallon¹⁰, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²University of Oxford, Oxford, United Kingdom, ³Universidade Federal do Paraná, Curitiba, Brazil, ⁴Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, ⁵Shores Rheumatology, St Clair Shores, MI, ⁶Dermatology Centre, University of Manchester, Manchester, United Kingdom, ⁷Pfizer Inc, Collegeville, PA, ⁸Pfizer Inc, Groton, CT, ⁹The Harris Poll, Rochester, NY, ¹⁰Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Patient (pt)–rheumatologist (rheum) communication may influence symptom reporting and disease control in psoriatic arthritis (PsA). This online survey evaluated pt–rheum communication and assessed PsA…
Abstract Number: 2342 • 2018 ACR/ARHP Annual Meeting
A Pan-Canadian Study of Factors Associated with Perceived Doctor-Patient Communication in Patients with Systemic Lupus Erythematosus
Deborah Da Costa¹, Carolyn Neville², Anne-Sophie Julien³, Murray Rochon⁴, Davy Eng⁵, Christine A. Peschken⁶, Evelyne Vinet⁷, C Douglas Smith⁸, Mark Matsos⁹, Janet E. Pope¹⁰, Ann E. Clarke¹¹, Stephanie Keeling¹², J. Antonio Avina-Zubieta¹³, Marie Hudson¹⁴ and Paul R. Fortin¹⁵, ¹Medicine, McGill University, Montreal, QC, Canada, ²Department of Medicine, McGill University Health Center, Montreal, QC, Canada, ³CHU de Québec - Université Laval, Quebec City, QC, Canada, ⁴Jack Digital, Toronto, ON, Canada, ⁵Centre de recherche du CHU de Québec, Université Laval, Québec, QC, Canada, ⁶RR 149G, University of Manitoba, Winnipeg, MB, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁸The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, ⁹Medicine, McMaster University, Hamilton, ON, Canada, ¹⁰Department of Medicine, University of Western Ontario, London, ON, Canada, ¹¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ¹²Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, ¹³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁴Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, ¹⁵Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity, which may require frequent encounters with the medical system…
Abstract Number: 2375 • 2018 ACR/ARHP Annual Meeting
When Are People Receptive to Self Management Education Information, and What Information Appeals to Them? : An Analysis of Digital Data
Teresa Brady¹, Meghan Lewis² and Carla Cartwright², ¹Clarity Consulting and Communications, Atlanta, GA, ²Porter Novelli, Atlanta, GA
Background/Purpose: CDC pilot-tested a marketing campaign to promote self-management education (SME) as a chronic disease management strategy. The campaign targets adults ages 45-75 with…
Abstract Number: 2941 • 2018 ACR/ARHP Annual Meeting
Reach and Effectiveness of a Health Communications Campaign Promoting Self Management Education: Results of a Pilot Test of the Learn More. Feel Better. Campaign
Teresa Brady¹, Meghan Lewis², Carla Cartwright², Anne Hvizdak³ and Sara Lasker⁴, ¹Clarity Consulting and Communications, Atlanta, GA, ²Porter Novelli, Atlanta, GA, ³Bureau of Aging and Disability Resources, Wisconsin Department of Health Services, Madison, WI, ⁴Healthy & Hygge, Madison, WI
Background/Purpose: Learn More. Feel Better. (LMFB) is a multi-modal marketing campaign to promote self-management education (SME) as a chronic disease management strategy. The campaign targets…
Abstract Number: PP07 • 2018 ACR/ARHP Annual Meeting
Strengthening My Resiliency: How My Interprofessional Healthcare Team and I Improved My Management of Lupus
Cecilia Amoakohene¹, Jorge Sanchez-Guerrero², Murray Urowitz², Dafna D Gladman², Zahi Touma² and Laura Wakani², ¹Unaffiliated, Toronto, ON, Canada, ²University of Toronto Lupus Research Program, Toronto Western Hospital, Toronto, ON, Canada
Background/Diagnosis: I was diagnosed with systemic lupus erythematosus (SLE) at the age of eleven and have experienced multiple SLE flares, hospitalizations, invasive procedures and complex…
Abstract Number: PP08 • 2018 ACR/ARHP Annual Meeting
Communication, Support, and Advocacy Lead to Improved Health and Quality of Life
Christele Felix, AztraZeneca, Gaithersburg, MD
Background/Diagnosis: In 2007 I was diagnosed with Lupus which has since then wreaked havoc on my kidneys, lungs, GI tract, peripheral nervous system, to name…
Abstract Number: 280 • 2018 ACR/ARHP Annual Meeting
Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus
R. Paola Daly¹, Nicole Wanty², Maggie Maloney¹, Stacey Boyd³, Karin Tse¹ and Karen Goldstein⁴, ¹Lupus Foundation of America, Washington, DC, ²KDH Research & Communication, Atlanta, GA, ³American College of Rheumatology, Atlanta, GA, ⁴Ogilvy, Washington, DC
Background/Purpose: Lupus is a complex, chronic autoimmune disease that has significantly higher prevalence and incidence among minority women.[i] In an effort to reduce the time…
Abstract Number: 1390 • 2018 ACR/ARHP Annual Meeting
Impact of Psoriatic Arthritis from the Patient’s Perspective in the Context of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire: An Online Global Survey
Laura C. Coates¹, Ana-Maria Orbai², Valderilio F Azevedo³, Joseph C Cappelleri⁴, Jade Moser⁵, Ralph Lippe⁶, Irwin Lim⁷, Lihi Eder⁸, Pascal Richette⁹, Meng-Yu Weng¹⁰, Rubén Queiro¹¹ and Lara Fallon¹², ¹University of Oxford, Oxford, United Kingdom, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Universidade Federal do Paraná, Curitiba, Brazil, ⁴Pfizer Inc, Groton, CT, ⁵The Harris Poll, Rochester, NY, ⁶Pfizer Pharma GmbH, Berlin, Germany, ⁷BJC Health, Sydney, Australia, ⁸Women’s College Research Institute, University of Toronto, Toronto, ON, Canada, ⁹Lariboisière Hospital, Lariboisière, University of Paris 7, Paris, France, ¹⁰Department of Internal Medicine, Division of Allergy, Immunology and Rheumatology, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan, ¹¹Rheumatology Division, HUCA, Oviedo, Spain, ¹²Pfizer Canada, Montreal, QC, Canada
Background/Purpose: Psoriatic arthritis (PsA) is a complex disease with high impact on quality of life (QoL). The PsA core domain set1 includes pain, patient (pt)…
Abstract Number: 358 • 2017 ACR/ARHP Annual Meeting
Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis
M. Elaine Husni^1,2, Anthony Fernandez¹, Rakesh Singh³, Brett Hauber⁴, Jessie Sutphin⁴, Joshua Posner⁴ and Arijit Ganguli³, ¹Cleveland Clinic, Cleveland, OH, ²Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, ³AbbVie Inc., North Chicago, IL, ⁴RTI Health Solutions, Research Triangle Park, NC
Background/Purpose: Psoriasis and psoriatic arthritis arise from the same immune system response but result in different symptoms and impacts on daily activities. A patient with…
Abstract Number: 1100 • 2017 ACR/ARHP Annual Meeting
Communication between Inpatient and Outpatient Specialty Clinicians: Developing a Better Understanding of Patients with Rheumatoid Arthritis Who Are Admitted to the Hospital
Abraham Tacang¹, Christina Downey², Alfred Denio¹, Eric Newman³ and Lisa L. Schroeder⁴, ¹Rheumatology, Geisinger Medical Center, Danville, PA, ²Geisinger Medical Center, Danville, PA, ³Department of Rheumatology, Geisinger Medical Center, Danville, PA, ⁴Rheumatology, Geisinger Health System, Danville, PA
Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatoid arthritis (RA). Communication between clinicians becomes even more crucial when a patient…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].